Baricitinib 4mg Tablets

Baricitinib 4mg is an oral JAK inhibitor used for rheumatoid arthritis and severe alopecia areata. It targets immune signalling involved in joint inflammation or immune-related hair loss.
Take once daily at a consistent time, with or without food. Kidney function, interacting medicines and the treatment indication determine the appropriate daily amount.
Baricitinib inhibits JAK1 and JAK2 enzymes, reducing the signalling of immune proteins that drive inflammation.
Respiratory infections, nausea, shingles and changes in blood-cell counts, liver enzymes or cholesterol can occur. Serious infections and blood clots are important risks.
Screening for tuberculosis and other infections is performed before treatment. New leg swelling, chest pain or sudden breathlessness needs urgent attention.
Can reduce inflammatory symptoms and, in eligible alopecia patients, support hair regrowth over time.
Reducing immune signalling can allow an inactive infection to become active.
No. It is a targeted JAK inhibitor with a different mechanism from corticosteroids.
No. Response develops over months and varies between patients with alopecia areata.
Live vaccines are generally avoided while immune responses are suppressed; vaccination planning is completed before treatment where possible.
JAK: an enzyme involved in immune-cell signalling. Alopecia areata: immune-related patchy hair loss. Rheumatoid arthritis: inflammatory autoimmune joint disease.; AR: Baricitinib 4mg أقراص; FR: Baricitinib 4mg comprimés; PT: Baricitinib 4mg comprimidos; ES: Baricitinib 4mg comprimidos; RU: Baricitinib 4mg таблетки; ID: Baricitinib 4mg tablet; VI: Baricitinib 4mg viên nén; MS: Baricitinib 4mg tablet; TL: Baricitinib 4mg mga tableta; ZH-SG: Baricitinib 4mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Baricitinib 4mg Tablets under Immunology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Baricitinib 4mg Tablets